About Us
Industries
Medical Devices
Medical Devices Classification
Cyber Security
Clinical Consultation
Quality Management System Compliance
Regulatory Compliance, Gap Analysis & Remediation
Clinical Evaluation Report CER
Market Compliance Consulting
Medical Devices Regulation (MDR)
In Vitro Diagnostic Regulation (IVDR)
Performance Evaluation Report (PER)
513g
510K
Pharmaceuticals
Biologics
Cosmetics
Review and Product Classification
Cosmetic Product Safety Reports (CPSR)
Cosmetics Claims and Substantiation Services
Cosmetic Labeling Review
Product Information / Technical File Compilation (PIF)
Go-to-Market Services and Regulatory Intelligence
Research & Development Solutions
Food Supplements & Nutraceuticals
Regulatory Overview and Product Classification
Food Ingredients and Additives
Claims and Substantiation of Claims
Labeling Review
Product Registration/Notification
Go-to-Market Services
Research and Development
Chemicals
Poison Center & Chemical Registry
Reach
Safety Data Sheet
House Hold and Personal Hygiene
Toys & Children Products
Veterinary
Services
Toxicological Risk Assessment
PDE Reports (Permitted Daily Exposure)
OEL & API Categorization
Nitrosamine Impurities
(Q)SAR Assessment
Impurities and Risk Analysis
Clinical Operations
Project Management
Clinical Monitoring
Site Startup
Site Service Solutions
Clinical Trial Site Management Organization (SMO)
Regulatory Affairs
Regulatory Services
Regulatory Strategy & Reports
Regulatory Compliance
Regulatory Consulting
Medical Writings
Compliance Audit and Validation
Clinical Informatics
NGS Data Analysis
Variant Interpretation Services
Content Enrichment Services
Pharma Competitive Insights
Health Economics and Outcomes Research
Registration and Notification
Life Cycle Management
Labeling Services
Artwork Services
Careers
Reports
Request Reports
PDE / OEL Report
Insights
Blogs
Events
Contact us
+44 148 290 6002
+1 786 623 2931
+91 906 383 8956
+91 900 001 9531
info@mavenrs.com
Maven Blogs
All
Food Supplements
Pharmaceuticals
Medical Devices
Cosmetics
Regulatory
Chemicals
May 23, 2026
Regulatory
Pharmaceutical Industry in Nigeria 2026: Key Regulatory Challenges Reshaping Pharma Market Entry
Learn more
May 18, 2026
Regulatory
CDSCO SUGAM Portal 2026: Long-Pending Applications Now Face Automatic Rejection & Fee Forfeiture
Learn more
May 12, 2026
Regulatory
FDA Real-World Evidence (RWE) 2026: The Ultimate Medical Device Regulatory Strategy Guide
Learn more
May 05, 2026
Regulatory
EU Fertilizing Products Regulation (FPR 2019/1009): Complete Compliance Guide 2026
Learn more
April 30, 2026
Regulatory
FDA Warning Letter 2026: AI in Pharmaceutical Manufacturing Does Not Replace Quality Unit Judgment or CGMP Accountability
Learn more
April 23, 2026
Regulatory
Dynamic Pharmaceutical Labeling Across Global Markets: 2026 Compliance Strategy
Learn more
April 15, 2026
Regulatory
FDA Approves First Generic Dapagliflozin Tablets: SGLT2 Inhibitor Regulatory Breakthrough in Type 2 Diabetes & Heart Failure Treatment (2026 Update)
Learn more
April 07, 2026
Regulatory
EMA GMP Guidelines 2026–2028: EU GMP Updates, Annex Revisions & Compliance Strategy for Pharma Industry
Learn more
April 02, 2026
Regulatory
Drug Registration Malaysia 2026: Complete NPRA Submission Dossier Guide (ACTD Format, GMP Compliance, Quest3+ & ASEAN Regulatory Strategy)
Learn more
March 24, 2026
Regulatory
ASEAN Medical Device Regulatory Reliance 2026: Malaysia MDA–Singapore HSA Pilot Success, Expedited Review Pathways & Global Market Access Strategy
Learn more
March 23, 2026
Regulatory
21 CFR Part 11 Compliance 2026: Complete FDA Guide to Electronic Records, eSignatures, Audit Trails, ALCOA+ Data Integrity, CSV & CSA Validation for Pharma, Biotech & MedTech
Learn more
March 21, 2026
Regulatory
Pharmaceutical Product Registration in Saudi Arabia (KSA): Complete SFDA Regulatory Approval Guide for Global Pharma Companies (2026)
Learn more
March 12, 2026
Regulatory
Mexico Medical Device & IVD Reliance Framework 2026: COFEPRIS Fast-Track Pathway for Global Regulatory Approvals
Learn more
March 07, 2026
Regulatory
UK FSA Reform & Regulated Products 2026: Post-Brexit Food Law, Novel Foods & CBD Authorization Strategy
Learn more
February 28, 2026
Regulatory
Swiss medic Importer Compliance 2026: Medical Device Regulatory Gaps & Enforcement Trends
Learn more
February 27, 2026
Regulatory
Pharma RIMS in 2026: Regulatory Information Management as the Backbone of Global Compliance
Learn more
February 26, 2026
Regulatory
Medical Device Regulations vs Standards: Key Differences Every Manufacturer Must Understand
Learn more
February 25, 2026
Regulatory
Ethnic Sensitivity in Global Drug Development 2026: ICH E5 Strategy, Bridging Studies & Regulatory Compliance Framework
Learn more
February 24, 2026
Regulatory
FDA Human Factors Expectations for AI-Enabled Medical Devices (2026): A Regulatory & Usability Framework
Learn more
February 23, 2026
Regulatory
AI-Driven Regulatory Information Management (RIM) for Post-Approval CMC Changes: 2026 Global Compliance Strategy for Pharma & Biotech
Learn more
February 21, 2026
Regulatory
TSCA Reform 2026: What the New U.S. Chemical Regulation Proposal Means for Manufacturers
Learn more
February 18, 2026
Regulatory
FDA 2026 Labeling Shift: “No Artificial Colors” Claims Now Allowed for Naturally Derived Color Additives
Learn more
February 17, 2026
Regulatory
Egypt Medical Device Post-Market Surveillance & Vigilance: New EDA Framework (2025–2026)
Learn more
February 16, 2026
Regulatory
FDA 2026 Enforcement on Compounded GLP-1 Drugs: Regulatory Crackdown on Non-Approved APIs & Marketing Claims
Learn more
February 16, 2026
Regulatory
ANVISA Regulatory Agenda 2026–2027: Strategic Compliance Roadmap for Pharma, Medical Devices & Food Industries
Learn more
February 12, 2026
Regulatory
Future-Ready Regulatory Strategy in 2026: AI-Enabled, Global, and Risk-Optimized Pathways for Pharma, Biotech & Medical Devices
Learn more
February 10, 2026
Regulatory
Health Canada REP 2026: New Medical Device Submission Process via CESG
Learn more
February 10, 2026
Regulatory
Global CTD Dossier Preparation & eCTD Submission Strategy (2026) for Pharmaceutical Regulatory Affairs
Learn more
February 05, 2026
Regulatory
Pharmaceutical Labeling Localization in Emerging Markets: Regulatory Requirements, Patient Safety, and Global Compliance Strategy (2026 Guide)
Learn more
February 03, 2026
Regulatory
EMA vs US FDA eCTD v4 Submissions: Critical Module 1 Differences Global Regulatory Teams Must Prepare for in 2026
Learn more
Load More
G
X
Back
Make an enquiry
Lets start the conversation!
Send
Sign up to our newsletter
Send
To explore career opportunities with us.
Send
